Back
Axsome Therapeutics Stock Price Chart
Your Data Made Them Billions-Now It's Your Turn to Profit
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
54
AXSM
Axsome Therapeutics
Last Price:
$121.95
Seasonality Move:
13.74%
7 Day Trial
ALL ACCESS PASS
$
7
The Tariff-Proof Asset in Your Pocket
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
The current trend is relatively stagnant and AXSM is experiencing slight selling pressure.
Axsome Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 122.47 | Sell |
| 20-day SMA: | 126.64 | Sell |
| 50-day SMA: | 109.75 | Buy |
| 200-day SMA: | 92.82 | Buy |
| 8-day EMA: | 122.54 | Sell |
| 20-day EMA: | 122.29 | Sell |
| 50-day EMA: | 114.07 | Buy |
| 200-day EMA: | 96.36 | Buy |
Axsome Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.4 | Buy |
| Relative Strength Index (14 RSI): | 52.03 | Buy |
| Chaikin Money Flow: | -24906 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (117.85 - 131.85) | Sell |
| Bollinger Bands (100): | (86.47 - 116.59) | Buy |
Axsome Therapeutics Technical Analysis
| Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb | Mar | |||||||||
| 28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Axsome Therapeutics Stock
Is Axsome Therapeutics Stock a Buy?
-
Axsome Therapeutics share price is 121.91 while AXSM 8-day simple moving average is 122.47, which is a Sell signal.
-
The stock price of AXSM is 121.91 while Axsome Therapeutics 20-day SMA is 126.64, which makes it a Sell.
-
Axsome Therapeutics 50-day simple moving average is 109.75 while AXSM share price is 121.91, making it a Buy technically.
-
AXSM stock price is 121.91 and Axsome Therapeutics 200-day simple moving average is 92.82, creating a Buy signal.
AXSM Technical Analysis vs Fundamental Analysis
Buy
54
Axsome Therapeutics (AXSM)
is a Buy
Is Axsome Therapeutics a Buy or a Sell?
-
Axsome Therapeutics stock is rated a BuyThe current Axsome Therapeutics [AXSM] share price is $121.91. The Score for AXSM is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
Axsome Therapeutics Stock Info
Market Cap:
5.9B
Price in USD:
121.91
Share Volume:
432.2K
Axsome Therapeutics 52-Week Range
52-Week High:
139.13
52-Week Low:
64.11
Buy
54
Axsome Therapeutics (AXSM)
is a Buy
Axsome Therapeutics Share Price Forecast
-
What is the Axsome Therapeutics stock price today?The Axsome Therapeutics stock price is 121.91 USD today.
-
Will AXSM stock go up or go down?Axsome Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Axsome Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Axsome Therapeutics is not overvalued.
Is Axsome Therapeutics Stock a Buy?
-
Axsome Therapeutics share price is 121.91 while AXSM 8-day exponential moving average is 122.54, which is a Sell signal.
-
The stock price of AXSM is 121.91 while Axsome Therapeutics 20-day EMA is 122.29, which makes it a Sell.
-
Axsome Therapeutics 50-day exponential moving average is 114.07 while AXSM share price is 121.91, making it a Buy technically.
-
AXSM stock price is 121.91 and Axsome Therapeutics 200-day simple moving average is 96.36, creating a Buy signal.
Fundamental Analysis of Axsome Therapeutics
Is Axsome Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.64 per share, an increase next quarter of $0.20 per share, an increase this year of $1.66 per share, and an increase next year of $5.27 per share.
Technical Analysis of Axsome Therapeutics
Should I short Axsome Therapeutics stock?
-
AXSM Moving Average Covergence Divergence (MACD) indicator is 2.4, suggesting Axsome Therapeutics is a Buy
-
Axsome Therapeutics Relative Strength Index (RSI) is 52.03, which suggest Axsome Therapeutics is overbought
-
The Bollinger Bands (25) for Axsome Therapeutics is (117.85 - 131.85), which suggest Axsome Therapeutics is a Buy
-
The Bollinger Bands (100) for Axsome Therapeutics is (86.47 - 116.59), which suggest Axsome Therapeutics is a Buy
* Axsome Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.